Status:

UNKNOWN

Myocardial Contrast Echocardiography in Septic Patients

Lead Sponsor:

Universitair Ziekenhuis Brussel

Conditions:

Sepsis

Microcirculation

Eligibility:

All Genders

19-85 years

Phase:

NA

Brief Summary

Myocardial microcirculatory alterations may be involved in the pathogenesis of acute cardiac dysfunction or septic cardiomyopathy in septic patients. The investigators study the cardiac function (syst...

Detailed Description

Using the IE33 device (Philips Medical Systems, the Netherlands), two-dimensional and myocardial contrast echocardiography (TTE and MCE) are performed following the recommendations of the American Hea...

Eligibility Criteria

Inclusion

  • Sepsis: a life-threatening organ dysfunction (defined as an acute change in total Sequential Organ Failure Assessment (SOFA) score \> 2 points consequent to infection) caused by a dysregulated host response to infection.
  • Sepsis shock : a subset of sepsis with persisting hypotension requiring vasopressors to maintain the mean arterial pressure \> 65 mmHg and having a serum lactate level \> 2 mmol/L after fluid resuscitation.

Exclusion

  • Non-survivors in the first 24 hours from sepsis
  • Sepsis post-acute cardiac arrest
  • Pregnancy
  • Younger than 18 years old
  • Acute Respiratory Distress Syndrome (ARDS) with the ratio of arterial oxygen partial pressure (mmHg) to fractional inspired oxygen (PaO2/ FiO2) \< 200)
  • Advanced malignancy
  • Untreated and unstable acute coronary syndrome
  • History of myocardial infarction with severe left ventricular dysfunction. (Ejection fraction \< 20 %).
  • Inoperable valvular and coronary disease
  • Significant right-left cardiac shunt
  • Untreated congenital heart disease
  • Severe systolic pulmonary hypertension \> 80 mmHg
  • Insufficient echogenicity
  • Prior anaphylaxis reaction to the Sonovue microbubbles

Key Trial Info

Start Date :

January 31 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04397640

Start Date

January 31 2020

End Date

December 31 2023

Last Update

May 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitair Ziekenhuis Brussel

Brussels, Belgium, 1090